Author / Colleen Quenzel
-
![Aspire Biopharma]()
Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA-Approved Drugs, Nutraceuticals and Supplements
Highlights Humacao, PR and New York, NY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Aspire Biopharma, Inc. (“Aspire” or the “Company”), a developer of a multi-faceted patent protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq: PWUP), a Nasdaq Global Market® listed special purpose acquisition company, (“PowerUp”), have entered into a definitive agreement and plan of merger…
Loading posts...
